This application claims priority under 37 C.F.R. 1.55 to Chinese Patent Application No. 2016-11211831.9 filed on Dec. 25, 2016.
The current invention belongs to the field of laser technology. Specifically, it relates to an optofluidic laser with an ultrasmall Fabry-Perot (TB) micro-cavity.
In general, biological fluorescent sensing and imaging are achieved mainly through the fluorescent signals produced by the excitation of fluorescent dyes or proteins on the biological samples. The characteristics of the fluorescent signals, including broad optical spectrum, non-directional emission, high signal noise, and low resolution, prevent biosensing with ultra-sensitivity and optical imaging with ultra-resolution. Micro-optofluidic, micro-cavity laser technology is one of the effective methods to address the above shortcomings in fluorescent imaging. The new laser technology utilizes the fluorescent markers (fluorescent dyes or proteins) on the biological samples (DNA, proteins, or cells) as the gain medium, transported to the micro-cavity through a micro-optofluidic control system and excited to produce laser signals. It replaces the fluorescent signals in the traditional sensing and imaging technologies with laser signals. Compared with the traditional fluorescent techniques, the micro-optofluidic laser technology has the following advantages:
Currently, micro-optofluidic laser technology has been widely used in the areas of high-sensitivity biological sensing, such as the assays for cellular structural changes and the enzyme-linked immunosorbent assay (ELISA). It has generally improved the sensitivity of the current sensing technology. However, the potential of high-resolution imaging of the micro-optofluidic lasers has not been fully explored. This Fabry-Perot type laser can be used for in vitro and in vivo high-resolution biomedical imaging with a resolution less than 100 nm. Specifically, for tumor cells, due to the modes and spectral characteristics of the cell-generated laser signals, this novel optofluidic laser can be used to analyze and characterize malignancy and subcellular structures of tumor cells as well as the tissue pathological changes.
The purpose of this invention is to provide an optofluidic laser with an ultrasmall Fabry-Perot cavity for high-resolution optical imaging.
This novel optofluidic laser combines new micro-optofluidic and micro-cavity technologies to achieve narrow-bandwidth laser output of stimulated emission from in vivo cells and tissue, for optical imaging as well as the acquisition and analysis of the laser spectrum, spatial mode, and other characteristic parameters of biological samples.
The micro-optofluidic laser with an ultrasmall Fabry-Perot micro-cavity in this invention consists of two highly reflective cavity mirrors and a micro capillary, of which the two mirrors are parallel distributed Bragg reflectors (DBRs) to form the resonant cavity (the FB micro-cavity). The top mirror is the output minor (high reflection and low transmission) and the bottom minor is totally reflective. The cavity length L is 30-50 um, the reflectance of the total reflective mirror is higher than 99.9%, and the transmittance of the output mirror is 2%-10%, as shown in
In this invention, the parallelism of the two surfaces of the each DBR is less than or equal to 3″.
In this invention, the parallelism of the surfaces of the total reflective mirror and the output mirror in the cavity is in the range of 5″ to 10″.
In this invention, the material for the two parallel DBRs can be artificial quartz crystal.
In this invention, laser gam medium can be water-soluble organic liquid materials and it can pass through the micro-cavity perpendicularly with a certain speed.
The mechanism this invention is as follows. To achieve the transmission of the optofluidic laser signals in Fabry-Perot micro-cavity with low threshold, the internal loss of the laser signals in the micro-cavity must be low, hence requiring the mirror surfaces of the micro-cavity to have high reflectance. Two DBRs are prepared with a reflectance higher than 99.9% for the total reflective mirror and a transmittance of 2 to 10% for the output mirror. The parallelism of each DBR reached 3″. In the traditional fluorescent sensing and imaging for biological samples, quenching is common. The current invention allows the biological cells or tissue to pass through the micro-fluidic channel with a certain speed, to obtain stable laser signals without fluorescent quenching, hence making the prolonged spectrum analysis feasible.
The current, invention replaces the traditional fluorescent signals with laser signals as the sensing and imaging medium, to achieve biological sensing with ultra-sensitivity and biological imaging with ultra-resolution.
This invention is, further described using the following example: laser pumping experiment with the micro-optofluidic chamber using alcohol containing coumarin dye as the gain medium.
Number | Date | Country | Kind |
---|---|---|---|
2016-11211831.9 | Dec 2016 | CN | national |